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INTRODUCTION 
    Wound healing requires energy and is a catabolic process. Patients who 
are severely malnourished demonstrate impaired wound healing and 
predisposition to infection. They also suffer deficient immune mechanisms. 
The catabolic effects of disease or injury can be reversed by adequate 
nutritional support. The degree of malnutrition is estimated on the basis of 
weight loss during the past 6 months, physical findings and plasma protein 
assessment. 
      Patient outcome can be predicted by a variety of valuable nutritional 
indices by means of risk stratification and objective comparison among 
patients but when used alone there is no consensus on the best method for 
assessing the nutritional status. Serum albumin level is the most readily 
available and clinically useful parameter. A serum albumin level greater then 
3.5g/dl suggests adequate protein stores. A serum albumin level less then 
3.5g/dl raises concern for potential surgical complications. 
     A body mass index of 19kg/m
2
 - 25kg/m
2 
 for an average adult suggests a 
normal nutritional status. A BMI of less than 18kg/m
2
 suggests potential 
surgical complication. 
     This study therefore aims at correlating preoperative serum albumin and 
Body Mass Index as predictors of  postoperative morbidity and mortality in 
elective major surgeries.       
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Serum albumin levels are to be measured along with BMI for all 
patients who are admitted for elective major abdominal surgeries in the 
Department of General Surgery, Coimbatore Medical College Hospital. 
Children < 12 yrs, patients having icterus, severe anemia (Hb < 7 gm/dl), 
diabetes mellitus, chronic renal disease, chronic liver disease were excluded 
from the study and so also patients on long term steroids or chemotherapy. 
The patients are to be followed  up after surgery and watched for 
complications like wound gaping, seroma formation, wound infection, flap 
necrosis, fistula formation etc. during the postoperative period. 
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AIMS AND OBECTIVES 
• To validate preoperative serum albumin and Body Mass Index as 
predictors of postoperative morbidity and mortality in elective major 
surgeries. 
 
 
 
 
 
 
 
 
 
 
 
  
4 
 
REVIEW OF LITERATURE 
 
NUTRITION IN SURGICAL PATIENT  
The primary aim of providing adequate nutrition in patients undergoin 
surgery is to prevent or reverse the catabolic effects of disease or injury. The 
efficacy of nutritional regimens has been determined by several important 
biological  parameters but the ultimate substantiation for nutritional support 
in surgical patients should be improvement in clinical outcome and 
restoration of function.
(5)
  
The incidence of post operative morbidities, such as intra –abdominal 
abscess, ileus and  anastomotic leakage may be brought down by the use of 
preoperative nutritional support. Patients with mild to moderate malnutrition 
need not be supplemented with preoperative nutritional support.
(2) 
 
Protein depletion results in delayed wound healing.  
Malnutrition leads to significant mortalities postoperatively and 
threefold increase in the post operative infection rate. Current indication for 
nutritional support before elective surgeries include a history of weight loss 
in excess of 10% of body weight or an anticipated prolonged post operative 
period of recovery during which the patient will be nil per oral.
(7)
 
The outcome of protein calorie malnutrition include a reduction in 
lean muscle mass, alteration in respiratory mechanics, impaired immune 
function and intestinal atrophy. These changes result in increased 
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postoperative morbidity due to impaired wound healing and  predisposition 
to infection.
(7) 
 
 
NUTRITIONAL ASSESSMENT:  
A comprehensive nutritional assessment comprises of the initial 
history, physical examination and laboratory testing to provide a snapshot of 
the patients recent nutritional health. 
 
 1) History:  
The underlying disease or a history of recent weight loss suggests the 
possibility of malnutrition. Anorexia, nausea, gastroesophageal reflux, 
vomiting, dysphagia, or a history of generalized muscle weakness should be 
investigated for further evaluation. Recent weight loss (5% in the last month 
or 10% over 6 months) or a current body weight of 80 to 85% (or less) of 
ideal body weight implies significant malnutrition.  
 
2) Physical Examination:  
Includes muscle wasting (thenar and temporal muscles), flabby or 
loose skin (loss of subcutaneous fat), and peripheral edema and/or ascites 
(hypoproteinemia). Hepatomegaly, glossitis, pallor, skin rash, hair changes, 
gingival lesions and dementia are some of the subtle findings of nutritional 
deficiency .  
6 
 
 
3) Anthropometric measurements:  
Anthropometry is the study that deals with the science of evaluating body 
size, weight and proportions. The body muscle mass (somatic protein) and 
fat reserve are reflected by measurements like MHMC ( mid humeral muscle 
circumference) and TSF ( triceps skin fold thickness) respectively. 
Various body compartments (mineral, fat, lean muscle mass) can be 
assessed by DEXA (Dual-energy X Ray absorptiometry) and it is made 
available in hospitals. Measurement of weight and height with calculation of 
BMI can be easily performed in the bedside or at the clinic. BMI is 
considered to be the most reliable indicator. These values determine the 
patients fat reserve with visceral and somatic protein mass.
(7) 
 
4. Laboratory tests that interpret malnutrition correlate with 
perioperative morbidity and mortality. 
• Serum albumin of less than 3.5 g% in a clinically stable,   hydrated 
patient indicate malnutrition. In dehydrated patients, serum albumin 
levels are normal inspite of malnutrition. Extravascular compartment 
contains two thirds of the body albumin stores, remaining one third in 
the circulation.  Plasma levels of albumin are lowered by trauma, 
sepsis and malignant diseases (catabolic states).  
Serum albumin has 14 -20 days as its half life. 
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• Serum prealbumin  indicates the acute change in nutritional status. It 
has a half life of 2-3 days.  
10-17 mg% - mild depletion  
5-10 mg% - moderate depletion  
<5mg% - severe depletion  
• Serum transferrin of less than 200mg% suggests malnutrition. It has 8 
-10 days as its half life. 
Malnutrition alters immune function. It can be assessed by  
• Delayed type hypersensitivity 
•  Total lymphocyte count (TLC) that is calculated by the formula  
TLC = %lymphocyte x WBC /100  
1500 – 1800 cells/mm
3
–mild depletion  
900 – 1500 cells/mm
3
– moderate depletion  
<900 cells/mm
3
– severe depletion 
 
NUTRITIONAL INDICES:  
They provide a means of objective comparison and risk stratification 
among patients. They aid surgeons in determining the correct timing for 
intervention and the progress being made towards the goal of adequate 
nourishment.
(7) 
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BODY MASS INDEX: (Quetelet’s Index)  
The Belgian Adolphe Quetelet invented this measure between 1830 
and 1850 during the course of developing “ Social Physics” 
11
 It is a 
statistical measure of the weight of a person scaled in relation to height. BMI 
is defined as an individual’s body weight divided by the square of their 
height. The extent to which a persons body weight departs can be assesed by 
calculating BMI from what is normal or desirable for a person of his or her 
height. The  deficiency or weight excess may, in part, be accounted for by 
body fat or muscle  
BMI  = weight(Kg) / height
2 
(m) 
 = 703 x weight (lb)/ height
2
(in)  
BMI correlates with body fat.  
BMI raises its advantage in yielding a better estimation of body fat 
than body weight.  BMI correlates with morbidity unlike the ideal body 
weight tables that were based on mortality data. It is used for both women 
and men
(9)
. 
Mortality and morbidity is correlated with both low and high BMI. 
Diminished work productivity and lethargy coincides with low levels of 
BMI. The lowest survivable levels of BMI have been estimated to be  12-
13kg/m
2
,
 
as suggested by observation in anorexia nervosa, famine and 
starvation or by theoretical models.  
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Recent studies suggested that the all cause mortality risk is higher for 
independently living older individuals with a BMI less than 22 kg/m
 2
. 
Owing to low BMI and inadequate dietary intake, the functional status 
has been diminshed among the older individuals in the community. There are 
few limitations of BMI. It may underestimate body fat in persons who have 
lost muscle mass (elderly) and may overestimate total body fat in persons 
who are very muscular (athletes). It will also inaccurately reflect body fat in 
edematous states or in individuals who are less than 5 feet tall
12
. 
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BMI is used in children differently. Here it is compared to typical 
values for other children of the same age but calculated in the same way as 
for adults. Rather than setting thresholds for underweight and overweight, 
the BMI percentile allows comparison with children of the same age and sex. 
A BMI that is less than the 5th percentile is considered underweight, 
between 85
th
 and 95th percentile at risk of being overweight and above the 
95
th
 percentile is considered overweight.
(11) 
 
PROGNOSTIC NUTRITIONAL INDEX (PNI):  
It has been experimented in patients undergoing either major cancer or 
gastrointestinal surgery and found to identify a subset of patients at increased 
risk of complications with accuracy. In addition, preoperative nutritional 
repletion has been shown to reduce post operative morbidity in this patient 
group.  
PNI =158 – [16.6 x Alb] – [0.78 x TSF] – [0.2 x TFN] – [5.8 x DH]  
Alb –  Albumin  
TSF  –  Triceps skin fold thickness (mm)  
TFN   –  Transferrin (mg/dl)  
DH  –  Delayed cutaneous hypersensitivity ;  
induration > 5mm =2  
1 -5 mm =1  
Anergy =0  
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PNI risk of complication  
Low <40%  
Intermediate 40 -49%  
High >50 %  
 
NUTRITION RISK INDEX (NRI) 
14
:  
The index uses serum albumin and weight loss as predictors of 
malnutrition and successfully stratifies perioperative morbidity and 
mortality. Of note, supplemental nutrition often fails to improve serum 
albumin levels, hence the NRI is not a tool for tracking the adequacy of 
nutritional support.  
NRI = [15.19 x Alb] +41.7 x [actual wt 9kg)/ Ideal wt (kg)]  
NRI = Well nourished >100  
Mild malnutrition 97.5 -100  
Moderate malnutrition 83.5 -97.5  
Severe Malnutrition <83.5  
Catabolic Index (CI)  
CI = [24 hr urine urea nitrogen excretion in g] – [0.5 x (dietary nitrogen 
intake in g)]  
No physiologic stress 0  
Mild stress 0-5  
Moderate to severe stress >5 
12 
 
 
ESTIMATION OF CALORIC REQUIREMENTS: (15) 
Adequate substrates are required for healing and tissue repair. Failure to 
provide adequate amounts of both calorie and protein leads to further 
depletion of lean body mass 
(3)
.  
 A modification of Herring equation has been implicated in the calculation of 
Basal Energy Expenditure (BEE ) :  
BEE in kcal/day in,  
Males : 16.4+ [13.7 x weight (kg)] + [5.0 x height(cm)] – [6.8 x age(yr)]  
Females: 655 + [9.6 x weight (kg)] + [1.7 x height(cm)] – [4.7 x age(yr)]  
The actual caloric requirement is obtained by multiplying BEE by a specific 
stress factor. Most stressed patients require 25 -30 kcal/kg/day  
TEE in kcal/day (Total energy expenditure)  
TEE = BEE x stress factor  
Selective stress factors  
• Starvation 0.8 -1.0 
• Elective surgery 1.0 -1.1  
• Peritonitis/other infections 1.05 -1.25  
• ARDS or sepsis 1.3 - 1.35  
• Cardiopulmonary disease 1.3 – 1.55  
• Pancreatitis or major burns 1.3-1.8 
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Estimation of protein requirement:  
The protein requirement differs according to the clinical condition and 
also the patient. The appropriate ratio of caloric: nitrogen is 150:1 (for a 
caloric: protein ratio of 24:1)  
Clinical condition Protein requirement  
(g/dl ideal body Wt/day) 
Normal person 0.8 
Elective hospitalization 1.00 – 1.10 
Complicated post operative case, 
infection 
1.20 – 1.40 
Major trauma, sepsis, pancreatitis 1.50 – 2.50 
 
Protein needs can also be assessed in serum albumin levels.
(11)  
 
  
Albumin (g/dl) 
 
Protein requirement 
(g/kg/day) 
Normal nutritional status >3.5 0.8 
Mild depletion 2.8 -3.5 1.0 – 1.2 
Moderate depletion 2.1 – 2.7 1.2 -1.5 
Severe depletion <2.1 1.5 – 2.0 
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METABOLISM OF PROTEINS, CARBOHYDRATES AND FATS: 
 Human body requires energy to maintain itself in a steady state. About 
50% of the basal metabolic rate (BMR) represents the work of ion pumping, 
30% reflects turnover of proteins and the remaining energy used for 
recycling of glucose, pyruvate , amino acids and lactate . Energy consumed 
during physical activity comprises 10 - 20%  of the total in hospitalised 
patients and about 10-50% in normal subjects.  
The increase in energy expenditure above basal is about 10% for 
elective surgeries, 10-30% for physical trauma and 50-80% for sepsis.  
Carbohydrates, proteins and fats are the sources of metabolic energy. 
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Carbohydrate Metabolism:  
 The body’s primary fuel source is constituted by carbohydrates 
normally that accounts for 30-40% of total caloric intake. Each gram of 
enteric carbohydrate yields 4 kcal of energy. Parenterally administered 
carbohydrate (example: IV dextrose) provides 3.4 kcal per gram.  
Salivary amylase initiates carbohydrate digestion and completion of 
absorption occurs within 1 - 1.5 m of small intestine. Starch is cleaved by 
salivary and pancreatic amylases into oligosaccharides. These molecules are 
hydrolyzed and transported by surface oligocassharides. 
 
More than 75% of carbohydrates that are ingested are broken down 
and absorbed as glucose.Insulin secretion from pancreatic beta cells is 
stimulated by hyperglycemia. Insulin then influences protein synthesis. 
A minimum intake of 400 kcal of carbohydrate per day reduces 
protein breakdown, especially after adaptation to starvation. Wound healing 
requires glucose as a major component, but excessive carbohydrate intake or 
repletion with excess amounts of glucose can result in hepatic steatosis and 
neutrophil dysfunction.  
Excess glucose from refeeding, as reflected by RQ >1.0,occurs in 
conditions such as thermogenesis, glucosuria and conversion to fat 
(lipogenesis).  
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Excessive glucose administration is deleterious in patients with 
suboptimal pulmonary function because of its elevated carbon-di-oxide 
production. 
It results in hyperglycemia, which may contribute to increased risk of 
infection and immune suppression. 
 As a result of carbohydrate deficiency breakdown of muscle tissues 
will occur. Fatiguability will set in as deficiency evolves. Cerebral 
metabolism diminishes and thinking capacity is hindered. 
 Deficiency also causes ketosis and ultimately weight loss which on a 
long run can cause acidosis. 
 In addition patient may have nausea, mood swings, dizziness, 
weakness and depression. 
 Hence adequate dietary carbohydrate is mandatory. 
 The following flow chart gives an over view of major pathways and 
their corresponding endproducts.  
17 
 
 
 
 
Fig.2: Carbohydrate metabolism - an overview showing major pathways 
and endproducts. 
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Protein metabolism:  
 Amino acids comprise proteins their and metabolism produces 4 
Kcal/gm of protein. Single aminoacids and dipeptides are produced by 
protein digestion that are absorbed by the gastrointestinal tract.  The process 
of digestion is initiated by gastric pepsin. Enterokinase, that are the principal 
effectors of protein degradation are found throughout the duodenal mucosa 
and  activate pancreatic proteases.  Once digested, almost 50% of protein is 
absorbed in duodenum and complete protein absorption occurs in the mid 
jejunum.  
A 70 kg person has a total body protein of 10 - 11 kg that is 
concentrated predominately in skeletal muscle. Daily protein turnover is 3 % 
of total body protein that accounts to about  250-300 g.  
The daily protein requirement in healthy adults is 0.8 g/kg body 
weight. Protein synthesis or breakdown can be determined  by measuring the 
nitrogen balance.Nitrogen of 1 g accounts to about 6.25g of protein intake.  
Nitrogen (balance) =Nitrogen (intake) – Nitrogen (output)  
Nitrogen (intake) = g  protein (intake)/6.25  
Nitrogen (output) = (UUNxVol) +3  
Where, UUN is urine urea nitrogen 
 vol is volume of urine produced over time of measurement. 
33
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There are 20 amino acids that are divided into essential amino acids and non 
essential amino acids, that depends on whether the synthesis is de novo. 
Major role of amino acids are:  
• Protein synthesis and recycling.  
• Energy generation through catabolic reactions  and carbon-di-oxide 
production. 
• Incorporation of nitrogen into non essential amino acids and 
nucleotides. 
• Transport and storage of small molecules and ions
18
 
Plasma aminoacid accumulation is regulated primarily by the hepatic 
metabolism of absorbed aminoacids. Urinary excretion amounts to about 10-
15g of basal nitrogen loss. A decrease of protein turnover occurs as age 
advances with  25g/kg/day in the neonate to 3g/kg/day in the adult 
 Glutamine: 
 It is a non essential amino acid that plays a vital role in the 
metabolically stressed patient. It is considered to be a crucial respiratory fuel 
for enterocytes. The decline of glutamine associated with injury or stress 
exceeds that of any other amino acids and persists during recovery even after 
the concentration of other amino acids has normalized. It is essential for 
lymphocyte production and macrophage function.  
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Arginine:  
 It is a substrate for the urea cycle and nitric oxide production. It 
improves nitrogen balance and wound healing, stimulates T-cell response 
and reduces the incidence of infective complications. It also improves 
albumin synthesis.  
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Lipid metabolism:  
 About 25 - 40 % of caloric intake in a typical diet is constituted by 
lipids. 9 kcal of energy is obtained from each gram of lipid.A functional 
jejunum and ileum along with co-ordination between pancreatic and biliary 
secretion is required for the complex digestion of lipid molecules.  
Duodenal introduction of fat results in secretion of secretin and 
cholecystokinin and these are essential for gall bladder contraction and 
pancreatic enzyme release, respectively.  
The hydrolysis of triglycerides to two fatty acids and a monoglyceride 
by lipase is falicitated by the alkaline environment of the duodenum. 
Emulsification is due to bile salts. Micelle formation is the most important 
step in lipid absorption, which helps absorption of fats across the mucosal 
barrier. The bile salt pool is maintained through reabsorption of bile salts and 
increased hepatic cholesterol synthesis. 
Increased hepatic synthesis of cholesterol compensates the intestinal 
bile salt losses. Bile salt pool would get depleted and fat malabsorption 
occurs due to major ileal resection.  Glucagon , catecholamines, steroids  
stimulates lipolysis that is inhibited by insulin. Dramatic lipolysis occurs due 
to stress. The cell membrane integrity is maintained by essential fatty acids 
linolenic acid and linoleic acid. The sole precursors of eicosanoid production 
are dietary fats. Generalized scaling rash , bony changes and hepatic 
steatosis occurs due its clinical deficiency.  
23 
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STRESS METABOLISM: 
Physiologic process, immunocompetence, wound healing and 
recovery from critical illness all depend upon adequate nutrient intake. 
 
STARVATION:  
Hepatic glycogen is depleted after an overnight fasting due to 
decreased plasma insulin and a rise in glucagon levels. After a day's fast , 
carbohydrate stores are depleted. Muscle glycogen is used after hepatic 
glycogen . Hepatic glucose metabolism must satisfy the energy demands of 
the hematopoietic and the central nervous system particularly the brain, 
which is dependant on glucose oxidation during acute starvation. Within 
approximately 10 days of starvation, the brain adapts to use fat as its fuel 
source.  
Thereafter brain relies on ketoacids produced by the liver. This has a 
protein sparing effect. Relative protein preservation , changes in the fuel 
consumption , and a decrease in basal expenditure of energy are the adaptive 
changes to starvation ( upto 30%). 
 
Physiologic stress: 
Sepsis, trauma and major operations resulting in interaction of 
endocrine and metabolic responses are divided into three phases 
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1) Catabolic phase:  
There is a dramatic increase in the metabolic demand after a major 
surgery that is reflected by an increase in urinary nitrogen excretion. 
Following a major surgery , depletion of proteins  initially occurs because 
patients commonly have an elevated basal metabolic rate and they are kept 
nil per oral. Physiological stress leads to hormonal responses that includes 
elevation in the serum glucagon , glucocorticoids and catecholamine levels. 
 
2) Early Anabolic phase: (Cortical withdrawal phase)  
Since it marks the shift from catabolism to anabolism, it ranges from 
several weeks to few months. A progressive gain in weight and muscle 
strength occurs during this phase due to positive nitrogen balance. The 
amount of energy lost in catabolic phase equals the amount of nitrogen 
gained. 
 
3) Late Anabolic phase:  
This refers to the last period of recovery that lasts for months to 
several weeks. Nitrogen balance equals as adipose tissue stores are lost 
gradually. 
Following elective operation, neural impulses carried via 
spinothalamic pathways activate the brain stem and thalamic and cortical 
centers which stimulate the hypothalamus. Hypothalamic stimulation 
27 
 
triggers combined neural and endocrine discharges. Nor epinephrine is 
released from sympathetic nerve endings. Epinepheine from the adrenal 
medulla, Aldosterone from adrenal cortex, ADHfrom posterior pituitary, 
insulin and glucagon from the pancreas and ACTH, TSH and GH from the 
anterior pituitary. These hormones produce secondary elevations of cortisol, 
thyroid hormone and somatomedins. The effects of the heightened 
neuroendocrine secretion include 
a) peripheral lipolysis from the synergistic activation of hormone 
sensitive lipase by glucagon, epinephrine, cortisol and thyroid 
hormone. 
b) accelerated catabolism, a rise in proteolysis stimulated by cortisol and 
c) decreased peripheral glucose uptake due to insulin antagonism by GH 
and epinephrine.  
The consequences are a marked rise in plasma concentration of free fatty 
acids, glycerol, glucose, lactate and amino acids. 
The liver responds with an increase in substrate uptake and glucose 
production, as a result of glucagon stimulated glycogenolysis and enhanced 
gluconeogenesis induced by cortisol and glucagon. 
Operation and trauma are neuroendocrine driven processes. The BEE 
rises by 10% in post operative patients. 
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Fig.7: The metabolic response to trauma is a result of neuroendocrine 
stimulation, which accelerates protein breakdown, stimulates 
gluconeogenesis, and produce glucose intolerance. 
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WOUND HEALING: 
Healing is a proliferative reaction that restores tissue integrity. 
 It involves the following processes. 
1. Induction of an inflammatory process in response to the initial injury 
with removal of damaged and dead tissue. 
2. Proliferation and migration of parenchymal and connective tissue 
cells. 
3. Formation of new blood vessels (angiogenesis) and granulation tissue. 
4. Synthesis of ECM proteins and collagen deposition. 
5. Tissue remodeling. 
6. Wound contraction. 
7. Acquisition of wound strength. 
 
Minimal intervention is required after a typical injury as wound healing 
per say is a normal orderly process. 
 
A normal wound healing state is achieved  after a variety of interventions 
that are required to shift and correct the wound healing process in chronic 
wound healing. Acute wounds are surgical or traumatic in origin. These 
wounds occur drastically and as a result of rapid and predictable repair 
process, results in closure.  
30 
 
 
 
Chronic wounds arise as a result of repeated insult to tissues, compromise to 
vasculature or chronic inflammation. They fail to go through the normal 
repair processes. They result in an untimely closure or improper wound 
closure.
(13)
 
 
WOUND HEALING PHASES:  
a. Inflammation and hemostasis  
b. Proliferation  
c. Maturation and Remodeling  
The immediate response to injury is the inflammatory phase (also called 
reactive phase). The body’s defence system aims to prevent further injury or 
to limit the amount of damage. The proliferative phase (also called 
regenerative or reparative phase) consists of re-epithelialisation, matrix 
synthesis and neovascularisation to relieve ischemic trauma itself . The final 
phase is maturational (or remodeling) phase which is defined as the period of 
contraction of the scar with cross linking of the collagen and loss of edema.  
 
 
 
 
31 
 
 
INFLAMATORY PHASE  
Inflammation occurs as an immediate reaction of the tissue to injury. 
Here an attempt is made to limit damage by stopping the bleeding, sealing 
the surface of the wound and removing any necrotic tissue, foreign debris or 
bacteria present. During the inflammatory phase, increase in vascular 
permeability, chemotactic migration of cells, cytokine secretion and growth 
factor migration to the inflammatory site occurs along with the migratory 
cell activation.
29 
 
 
HEMOSTASIS AND INFLAMMATION  
Vascular damage occurs after an acute tissue injury exposing the 
subendothelial collagen to platelets.This leads to activation of coagulation 
pathway after the process of platelet aggregation. Initially increase in 
vascular permeability occurs due to vasodilatation that follows intense 
arteriolar and capillary vasocostriction. The platelets and erythrocytes adhere 
to the  damaged caplillary endothelium  along with capillary plunging , thus 
ceasing hemorrhage. Architecture as of the pre existing tissues is achieved 
by regenerartion with absence of scar formation .Regeneration though the 
goal of wound healing, is found only in early embryonic development or in 
certain tissues such as liver and bone. 
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However, the accuracy of regeneration is sacrificed for the  
inflammatory phase in wound healing of adult humans.  
 
PROLIFERATIVE PHASE  
Wound repair begins to start as the acute responses such as hemostasis 
and inflammation resolves through angiogenesis, fibroplasia and 
epithelialisation. During this phase formation of granulation tissue takes 
place which consists of hyaluronic acid, fibronectin, loose collagen 
arrangement, macrophages, fibroblasts and the capillary bed. 
 
ANGIOGENESIS  
It is a phenomenon of new vasculature formation .It supports the 
healing wound environment after injury. The basement membrane of post 
capillary venules are degraded by the activated endothelial cells, thereby 
allowing the migration of cells through the gaps. Division of the endothelial 
cells that migrate takes place resulting in tubule or lumen formation. 
Eventually capillary maturation occurs due to deposition of the basement 
membrane.  
 
FIBROPLASIA  
In connective tissues, the resting mesenchymal cells are differentiated 
to form the specialised cells called fibroblasts. Following an injury,  the 
33 
 
normal fibroblasts that are dormant and scanty divide and produce the 
components of extracellular matrix, after being chemoattracted to the 
inflammatory site. The fibroblasts' chief function is considered to be the 
synthesis of collagen. The time needed for undifferentiated mesencymal cells 
to differentiate into highly specialised fibroblasts is the delay between injury 
and the collagen appearance in the healing wound. This period depends on 
the type of tissue injured. It generally takes 3 to 5 days, known as the lag 
phase in the process of wound healing.  
The collagen synthesis rate declines after 4th week and  balances rate 
of collagen destruction eventually with the aid of  collagenase. The wound 
enters  the collagen maturation phase at this point . The maturation phase 
extends for months and years. During the maturation phase  glycoprotein and 
mucopolysaccaride levels decrease and new capillaries revert and disappear. 
All these changes increase the wound strength and also alter the appearance 
of wound. 
 
  
EPITHELIALISATION:  
Re-epithelialisation of wound begins within hours after injury and 
takes 48 hours to complete in case of approximated incised wounds. Initially 
wound is quickly sealed by formation of clot and then by migration of 
epithelial cells across the defect. Keratinocytes are situated at basal layer of 
the residual epidermis and also in depths of dermal appendages lined by 
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epithelium. These migrate to re surface the wound. Epithelialisation is 
characterized by a series of changes in the wound that is detachment, 
migration and proliferation after which follows the differentiation and later 
stratification. Epithelialisation proceeds more rapidly only when the 
basement membrane zone is intact.  
 
 
EXTRACELLULAR MATRIX  
The ECM provides a scaffold for the stabilization of the physical 
structure of the tissues. Cells within it produces the macromolecular 
constituent that includes the following: 
• Glycosaminoglycans, or polysaccharide chains are usually found 
linked covalently to protein in the form of proteoglycans.  
• Fibrous proteins that includes collagen, fibronectin , elastin and 
laminin.  
The wound matrix accumulates and changes in composition take place as 
healing progresses, maintaining a balance between new deposition and 
degradation. The provisional matrix exists as a scaffold for cellular 
migration and composed of fibrin, fibrinogen, fibrinonectin, and vitronectin. 
Glycosaminoglycans and proteoglycans which are synthesized later  aid in 
matrix deposition and remodeling. Collagen which are the major scar 
proteins are the final results. 
(32)
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WOUND CONTRACTION:  
The wounds undergo certain degree of contraction. The myofibroblast  
is the major cell responsible in this process. These cells start appearing from 
day 6. Immediately after injury the wound contraction almost begins. The 
cellular movement with concomitant cytoskeleton reorganization is 
responsible for  the wound contraction.  
 
 
WOUND STRENGTH :  
At the 1st week end, the strength of the wound is roughly  10% that of 
a normal unwounded skin, which quickly increases within  next 4 weeks. By 
the end of 3rd month, a plateau accounting for about 70% to 80% of the 
normal unwounded skin's tensile strength, is reached. This condition may 
persist for life. The excess of collagen formation over collagen destruction 
during the 1st 2 months of healing and at later times from structural 
modification of collagen fibres (cross linking, increased fibre size) after 
cessation of collagen synthesis is found to be responsible for the recovery of 
tensile strength.
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 This picture clearly depicts the various wound healing phases where 
the inflammatory phase in the earlier stages progresses to granulation tissue 
formation and ultimately wound contraction. Subsequently collagen 
accumulation and  remodelling occurs. 
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 The pictorial representatives clearly depict the various histological 
stages where in platelets start aggregating once the subendothelial collagen 
matrix is exposed, with subsequent accumulation of lymphocytes and 
macrophages  and the meshwork of collagen, fibrolasts migrate to the wound 
site and thus aid in healing. 
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Fig: 10: Cascade of events in wound repair process: 
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Based on timing of wound healing they are classified into:  
A. Healing by primary intention  
B. Healing by secondary intention  
C. Healing by tertiary intention or delayed primary closure 
 
 HEALING BY PRIMARY INTENTION:  
It occurs when the wound is closed by direct approximation of the 
wound margins or by placement of a graft or flap. Wounds that are less than 
6 hrs old are considered and are less likely to develop into chronic wounds.  
 
HEALING BY SECONDARY INTENTION:  
It occurs when a wound is left open and is allowed to close by 
epithelialization and contraction. It is commonly used in the management of 
wounds that are treated beyond the initial 6 hrs.  
 
HEALING BY TERTIARY INTENTION:  
It is used for wounds that are heavily contaminated for primary 
closure but appears clean and well vascularised after 4-5 days of open 
observation so that the cutaneous edges can be approximated at that time.  
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ABNORMAL WOUND HEALING:  
In such a complex series of intervening events as wound healing, 
multiple factors can impede the outcome affect. The factors that affect the 
time of recovery are the amount of tissue lost or damaged, the amount of 
foreign material or bacterial inoculation and the length of exposure to toxins. 
The greater the insult, the   longer the reparative process and the greater the 
amount of residual scar. Intrinsic factors that affect wound healing are 
chemotherapeutic agents, atherosclerosis, cardiac or renal failure. The blood 
supply in the lower extremity is the worst in the body and that on the face 
and hands is the best. 
 
FACTORS THAT INHIBIT WOUND HEALING: 
• AGE - the older the patient, the slower the healing. 
 
• MALNUTRITION- Through major direct and indirect effects, the 
normal healing mechanism is altered by malnutrition. In order to 
prevent infection, adequate nutrition is necessary which aids in 
maintaining a competent immune system. 
Normal tensile strength and collagen framework synthesis needs iron, 
magnesium, zinc, vitamins A and C, calories and adequate proteins. 
Delay in wound healing is due to protein catabolism.  
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• INFECTION - Hypoalbuminemia predisposes to infection due to 
compromised immunity. Infected wounds lead to tissue destruction by 
prolonging the phases of inflammation, delaying collagen synthesis, 
preventing epithelialization and increasing the production of 
inflammatory mediators like cytokines. 
Presence of more than 10 bacteria signifies infection. Critical factors of 
infectivity are concentration, virulence, and host resistance 
 
• DIABETES MELLITUS (DM) - Impaired wound healing in diabetic 
patients is well established. Reduced collagen synthesis and deposition 
and decreased tensile strength characterise the wound repair in patients 
with DM .  
 
•  A direct relationship between tensile strength and glycosylated 
hemoglobin levels have been described. The differences in wound 
repair is partially explained by increased levels of proteases, decreased 
levels of  proliferative cytokines and abnormal insulin levels. DM also 
results in compromised perfusion, patients with DM are at high risk of 
microvascular diseases. Consequently the delivery of micronutrients at 
the capillary level is impaired and there is an increase in vascular 
permeability. All these factors increase infection risk and diminished 
support for wound healing.  
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• OBESITY - It is  independently a risk factor for impaired wound 
healing. Adipose tissue is poorly vascularized. In addition cardiac 
function is frequently compromised in obese patients, further 
diminishing tissue perfusion. As a result infection, seroma formation, 
anastomotic leak and wound dehiscence are all more common among the 
obese population.
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• MEDICATION - Chemotherapeutic drugs and NSAIDS aree the 
medications compromising wound repair. Former have an impact over 
rapidly dividing cells. The cells more profoundly affected are fibroblasts 
and myofibroblasts which would result in impaired collagen synthesis 
and wound contraction.  
 
• STRESS - It impairs wound healing as a potential co factor with its 
physiological and psychological means. Stimulation of sympathetic 
nervous system and elevation of serum corticosteroid levels leads to 
compromise of immune function and perfusion due to vasoconstriction 
as a result of stress. 
 
• IMMUNOSUPPRESSION- Immunosuppression increase susceptibility 
to infection and retards wound healing and this is attributed primarily to 
impairment of the inflammatory process. 
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•  RADIATION THERAPY - It causes damage to the keratinocytes and 
fibroblasts as well as nutrient blood vessels resulting in delayed healing . 
 
• CIGARETTE SMOKING - It affects both perfusion and 
oxygenation.Nicotine, carbon monoxide, and hydrogen cyanide are the 
three byproducts of cigarette smoking  . Nicotine is a potent 
vasoconstrictor and potentiates platelet aggregation, the oxygen 
saturation is lowered due to carbon monoxide and cellular oxygen 
transpost is depleted by hydrogen cyanide. Therefore there exists a high 
incidence of wound infection, dehiscence and delayed healing among 
smokers.
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• LOCAL FACTORS - The local factors that affect the repair process are 
wound bed desiccation, pH, hypothermia, excess wound fluid, and/ or 
heavy bacterial colonization. A moist, clean wound surface that is 
maintained at a temperature of about 30 degree Celsius supports wound 
healing to the best.  
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SURGICAL SITE INFECTION  
These refer to the infections that are present along a surgical tract in 
any location after a surgical procedure.  SSI  is defined by the Centre for 
Disease Control and Prevention as the one that can occur on any post 
operative day ranging from 0 to 30 days to as late as 1 year in procedures 
such as implantation of mesh. 
Classification 
• Incisional superficial SSI  
• Incisonal deep SSI  
• Organ/space related  
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SUPERFICIAL INCISIONAL SSI  
Infection that occurs within the 30 th post operative day involving 
only the subcutaneous tissue and skin along with either one of the following  
a. Purulent discharge  
b. Isolating organisms from aseptically cultured tissue and fluid. 
c. At least one sign of infection : Localised swelling, tenderness or pain, 
warmth and incision is deliberately opened by surgeon unless the 
incision is culture negative  
d. Diagnosis of SSI by an attending physician or surgeon.
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DEEP INCISIONAL SSI 
Infection occurring within 30 days of surgery or within 1 year of 
operation if implants are in place and infection involving deep soft tissue; 
and at least one of the following 
a. Purulent discharge  
b. Deep incision spontaneously dehisces or is deliberately opened by a 
surgeon when the patient has at least one of the following symptoms; 
fever more than 38 degree Celsius, localized pain or tenderness unless 
the site is culture negative. 
c. Evidence of deep infection on direct examination , during reoperation 
or on radiological examination. 
d. Diagnosis of SSI by an attending physician or surgeon.  
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ORGAN/SPACE SSI:  
Infection occurring within 30 days of surgery or within 1 year of 
operation if implants are in place and infection involving any part of 
anatomy that was manipulated during an operation, other than the incision 
and at least one of the following:  
 
a. Purulent discharge that is placed through a stab wound into the organ 
space.  
b. Organisms isolated from an aseptically cultured fluid or tissue. 
Evidence of deep infection on  direct examination, during reoperation, 
or on radiological examination.  
c. Diagnosis of SSI by an attending physician or surgeon.  
 
About 38% of all infections in surgical patients are due to nosocomial 
infections among which SSI are more common. Among them incisional SSI 
are the most common. Organ /space related SSI account for 93% of SSI 
related mortality and thus have worser prognosis than incisional SSI's  that 
account for 60 - 80% of all SSI's. 
The most common pathogen in SSI is Staphylococcus aureus followed by 
coagulase negative staphylococcus, enterococci, and E.coli. Bacterial 
contamination of >10 organisms frequently causes infection whereas 
contamination with < 10 organisms usually does not. 
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Synthetic Hernia Mesh 
Mesh is either synthetic – a knitted material or non-knitted sheet. It 
may be absorbable, or non-absorbable or a combination of both. Non-
absorbable mesh, which is mostly synthetic, will stay in the body 
indefinitely. It is a permanent implant and difficult to remove. 
Animal-Derived Hernia Mesh 
Animal-derived mesh can be made from animal tissues, such as the 
intestine or skin of a pig (porcine) or cow (bovine) that is processed and 
sterilized. Animal-derived mesh is absorbable. 
Over time, absorbable mesh will degrade and lose strength while new 
tissue growth takes over to strengthen the repair. 
Complications associated with hernia mesh are: 
∗ Mesh related adverse reactions 
∗ Adhesions  
∗ Injuries to adjacent vasculature , neuronal structures or organs  
∗ Additional complications with or without mesh can include infection, 
chronic pain and hernia recurrence. 
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Complications can include pain, nerve entrapment, reduced movement, and a 
foreign object reaction that can include fever, swelling, and general malaise. 
  
Mesh in situ 
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SURGICAL WOUND CLASSIFICATION ACCORDING TO 
DEGREE OF CONTAMIMATION : 
A. Clean:  
Uninfected operative wound in which no inflammation is encountered 
and respiratory, alimentary, genital, or infected urinary tract is not entered. 
Wounds are closed primarily and if necessary drained with closed drainage. 
Surgical wounds after blunt trauma should be included in this if they meet 
the criteria.  
 
B. Clean contaminated:  
An operative wound in which the respiratory, alimentary, genital or 
urinary tract is entered under controlled conditions and without unusual 
contamination.  
 
C. Contaminated:  
Open, fresh, accidental wounds. In addition operation with major 
break in the sterile technique or gross spillage from gastrointestinal tract and 
incision in which acute nonpurulent inflammation is encountered are 
included in this category.
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D. Dirty:  
Old traumatic with retained and devitalized tissue and those that 
involve existing clinical infection or perforated viscera .This definition 
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suggests that the organisms causing postoperative infection were present in 
the operative field before the operation. The accepted range of infection rates 
has  been 1-5% for clean, 3%-11% for clean contaminated , 10%-17% for 
contaminated, and >27% for dirty wounds.  
 
Fig.14 Southampton wound grading system: 
Grade Appearance 
0 Normal healing 
1 Normal healing with mild bruising or erythema 
1a Some bruising 
1b Considerable bruising 
1c Mild erythema 
2 Erythema + other signs of inflammation 
2a At one point 
2b Around sutures 
2c Along wound 
2d Around wound 
3 Clear or haemoserous discharge  
3a At one point only (<2cm) 
3b Along wound (>2cm) 
3c Large volume 
3d Prolonged (>3days) 
Major complications 
4 Pus 
4a At one point only (<2cm) 
4b Along wound (>2cm) 
5 Deep or serve wound infection with or without tissue 
breakdown; haematoma requiring aspiration 
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PULMONARY COMPLICATIONS:  
There are numerous factors accounting for the altered pulmonary 
dynamics post operatively. In nearly all patients , there is a loss of functional 
residual capacity. 
 
This can arise through an array of problems, that includes abnormal 
distension, a painful upper abdominal incision , obesity, a strong smoking 
history with associated COPD, prolonged supine positioning, and fluid 
overload leading to pulmonary edema.  
 
Two types of respiratory failures are commonly described. Type1 or 
hypoxic with a low PaO2 and normal PaCO2. Type2 failure is associated with 
hypercapnia and is characterized by a low PaO2 and high PaCO2.  
 
The candidates who all must be carefully screened with PFTs include 
patients with a history of heavy smoking, patients maintained on home 
oxygen, patients who are unable to walk one flight of stairs without severe 
respiratory compromise, patients with a previous history of major lung 
resection, and elderly patients who are malnourished.
(14) 
 
Several studies show that hypoalbuminemia is related to a high risk of 
pulmonary complications and a higher overall mortality.
(8)  
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PLASMA PROTEINS:  
The major solid components of plasma are made up of the total 
proteins that costitiute 7 to 7.5 g/dl. Varied types of lipoproteins and 
conjugated proteins also include itself along with simple proteins in the 
complex mixture of plasma proteins. Though under normal circumstances 
the amount of individual antibodies are low, there are thousands of 
circulating antibodies. Globulins, albumin and fibrinogen are the three major 
groups of antibodies. 
The most common method used for analysis of plasma proteins is 
electrophoresis. 
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Functions of plasma proteins: 
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ALBUMIN:  
About 60% of total plasma proteins is constituted by the major protein 
of human plasma - albumin. The normal serum value is between 3.5-5.5 g/dl. 
Molecular weight is 69kda.
(15) 
 
The total exchangeable pool of albumin is 4-5g/kg body wt; between 
6-10% of the exchangeable pool is degraded per day. 
(16) 
 
 Human albumin does not increase the viscosity of plasma due to its 
ellipsoid shape and consists of 17 disulfide bonds and 585 aminoacids 
arranged in a single polypeptide chain. It accounts for 75-80% of human 
plasma 's osmotic pressure. Total protein of greater than 5 g/dl and serum 
albumin of greater than 2.5 g/dl is needed to produce adequate oncotic 
pressure. 
Albumin synthesis is decreased during fasting and in cases of protein 
malnutrition.
(16)
 
Albumin is an acute phase protein the concentration of which is 
decreased by at least 25% following injury. 
Time course of changes occurs in some major acute phase proteins. 
C3, C3 component of complement. 
(Modified and reproduced with permission, from Gitlin JD, Colten 
HR: Molecular biology of acute phase plasma proteins. In Pick F et al 
[editors].  
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EXTENT OF MALNUTRITION  
• Normal- 3.5-5.5gm/dl  
• Mild – 2.8-3.5gm/dl  
• Moderate -  2.1-2.7gm/dl  
• Severe- <2.1gm/dl  
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CAUSES OF HYPERALBUMINEMIA (>5.5g/dl)  
There are no known pathological causes for a raised plasma albumin.  
Causes include:  
a. Dehydration: this is also reflected in an increase in plasma total 
protein, a raised hematocrit and appropriate clinical features.  
b. Venous stasis  
c. Albumin infusion  
 
CAUSES OF HYPOALBUMINEMIA (<3.5g/dl)  
a. Increase in plasma H 
This occurs as a part of physiological response in pregnancy. 
Other causes include, excessive infusion of IV fluids, water retention 
in SIADH, glucocorticoid deficiency.  
 
b. Diminished synthesis-  
Any cause of generalized protein malnutrition will ultimately be 
reflected in low plasma albumin. Causes for this include deficient diet 
in protein nitrogen, protein malabsorption such as coeliac disease, 
tropical sprue, crohn’s disease, cystic fibrosis, decreased synthesis in 
chronic liver disease and in hereditary analbuminemia where there is a 
marked impairment of albumin biosynthesis with plasma levels which 
are typically low.  
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c. Increased catabolism-  
This is a feature of hypercatabolic state. The important feature 
of hypercatabolic state is the stress related stimulation of 
glucocorticoid production. These hormones are known to stimulate 
protein catabolism. Condition such as fever, trauma, major surgery, 
severe sepsis, malignant disease may all be associated with varying 
degrees of hypoalbuminemia.  
 
d. Losses of albumin from body-  
Sites of excessive loss are GI tract, kidneys and skin.
(17)
 
Hypoalbuminemia correlates itself with immune response impairment 
such as activation of macrophages and formation of granuloma, 
decreased wound healing mechanics , and impairment of collagen 
meshwork synthesis at surgical wounds and anastomotic sites .This 
signifies the reason why infections such as pneumonia , wound 
infection and anastomotic site leakage were commonly found among 
patients with hypoalbuminemia.
(37)  
 
Gibbs et al studied the precision and reliability of estimates of 
the association between preoperative serum albumin concentration and 
surgical outcome. A total of 54,215 major non cardiac cases were 
studied.Serum albumin decrease from concentration  > 46gm/dl to       
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< 21gm/dl was related with an exponential increase in mortality rates  
from <1% to 29% and in morbidity rates from 10% to 65%. Albumin 
levels were a better predictor of morbidities, particularly major 
infection and sepsis. Serum albumin is a better predictor of surgical 
outcome than many other preoperative patient characteristics. It is a 
relatively low cost test that should be used more frequently as a 
prognostic tool to detect malnutrition and risk of adverse surgical 
outcomes.  
A retrospective study by Kudsk et al of 526 surgical patients 
who had preoperative serum albumin levels measured and were 
undergoing elective esophageal , gastric, pancreaticoduodenal or colon 
surgery, serum albumin levels below 3.25g/dl correlated immensely 
with complications, length of stay, postoperative stay and mortality.  
In a study done by M.B. Badia et al of 158 patients on 
multivariate analysis, preoperative  hypoalbuminemia was 
significantly associated with higher morbidity and lengthier hospital 
stay regardless of the type of surgery.  
In a study done by Detsky et al on 202 patients who were 
planned for gastrointestinal surgery, several techniques of nutritional 
assessments were adapted to predict major post operative 
complications. Subjective global assessment (SGA) and albumin were 
both of predictive value , and combination of these variables were 
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useful in differentiating low risk from high risk patients. It was 
concluded in a study that SGA and albumin are useful “nutritional 
assessment techniques” for patients undergoing major gastrointestinal 
surgeries if the purpose of such an assessment is to predict 
postoperative nutrition associated complications.  
A meta-analysis of cohort studies and controlled studies of 
hypoalbuminemia in acute illness; is there a rationale for intervention 
by Vincent et al
(23)
 shows that hypoalbuminemia was a potent dose 
dependant , independent predictor of poor outcome. Each 10g/dl 
decline in serum albumin concentration significantly raised the odds 
of mortality by 137%, morbidity by 89%, prolongs icu and hospital 
stay by 28% and 71%  respectively.  
A serum albumin level of <2g/dl  in critically ill patients has 
been shown to be associated with a mortality of nearly 100%. The 
association between  hypoalbuminemia and poor outcome appeared to 
be independent of both nutritional status  and inflammation. The 
complication rates may be reduced when serum albumin level attained 
during albumin administration exceeds 30g/dl. Complications were 
higher when serum albumin level was lower than 2.5g/dl in  critically 
ill adult patients in a study by Foley et al. 
(24)  
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In a prospective randomized clinical study by Woods et al
(25)
 
done to identify the role of serum albumin concentration on length of 
post operative illness , the hypothesis was that patients whose albumin 
levels dropped below 3.5g/dl would have a more prolonged 
postoperative hospital course as a result of delay in return of bowel 
function. Increased incidence of pneumonia, wound infection, 
septicemia postoperatively was reported by Brown et al
(26)
 in their 
study in patients with serum albumin levels < 3g/dl. 
Golub et al
(27)
 studied the effect of hypoalbuminemia (serum 
albumin levels <3g/dl) upon  admission of patients to surgical icu due 
to vascular insufficiency, hip fractures, gastrointestinal bleeding , 
cancer, perforated viscus, intra-abdominal infection or bowel 
obstruction. Complications were higher in patients with 
hypoalbuminemia (36.9%) and  mortality of (5.8%).  
In a study by Beghetto et al
(28)
 done on 434 patients who were 
evaluated for the accuracy of nutritional assessment tools for 
predicting adverse hospital outcomes, it was concluded  that serum 
albumin level was the strongest  predictive parameter for death and 
hospital infection (<3.5g/dl). A BMI <18.5 kg/m
2
 was also associated 
with death and infection postoperatively and increased length of 
hospital stay. 
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Liop et al 
(29) 
found that a serum albumin below 3.5g/dl at the 
onset of treatment was a predictor of kidney and liver  failure, hospital 
infection, and mortality in 12 patients strata.  
While assessing 6 patients submitted to elective urology and 
gynecology surgical procedures, Anderson et al 
(30) 
observed that low 
albumin had a sensitivity of 22% and a  specificity of 91% in 
predicting hospitalization lasting more than 10 days and a sensitivity 
of 10% and specificity of 86% for complications.  
Hirsch et al
(31)
 in a prospective study assessed the  preoperative 
nutritional status of surgical patients and its relation to postoperative 
outcomes. Preoperative nutritional assessment included anthropometry 
and biochemical indices. The more useful parameters were 
preoperative weight loss and low serum albumin levels.  
Leite et al 
(32) 
in their article studied the effect of serum albumin 
and clinical outcome in paediatric patients undergoing cardiac surgery. 
A low serum albumin level (<3g/dl) was associated with a poor 
postoperative outcome which included increased postsurgical 
infection, increased mortality and longer hospital stays.  
Engelman et al
(33)
 studied the importance of BMI and serum 
albumin on mortality and morbidity after cardiac surgery. Serum 
albumin levels <2.5g/dl was associated with risk and BMI <20kg/m
2
 
and > 30kg/m
2
 was associated  with increased rates of infection.  
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Mullen et al 
(34)
 studied the impact of BMI on preoperative 
outcome in patients  undergoing major intra-abdominal surgery. Being 
under weight was associated with higher mortality and wound 
infection was more common in the obese. 
(61)
 
A study by Arozullah et al 
(35)
 on the preoperative evaluation for 
postoperative pulmonary complications showed that low albumin 
levels was associated with respiratory failure and higher postoperative 
mortality and morbidity rates. Moreover morbidity increases 
exponentially as albumin levels fall below 4g/dl. Patients with >10% 
weight loss in 6 months prior to surgery are at increased risk for 
pneumonia and respiratory failure.  
In a study done by Daniel et al 
(36)
 on 183,069 pts subjected to 
general and vascular  surgeries , it was determined through a logistic 
regression analysis that a serum albumin  <3.5g/dl and weight loss 
>10% was associated with cardiac complication with a significant p 
value(0.0001).  
In a study by Varut et al 
(37)
 244 patients subjected to rectal 
cancer surgery, an assessment  of the role of preoperative  serum 
albumin as a risk factor for postoperative outcome was studied. It was 
concluded that preoperative hypoalbuminemia (<3.5g/dl) is an 
independent risk factor for postoperative complications following 
rectal cancer surgery including mortality. Complications, time to first 
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bowel movement, time to first defecation, time to resumption of 
normal diet and length of hospital stay. Azodi
(38)
 studied the impact of 
BMI and tobacco smoking on outcome after open appendicectomy. 
They concluded that tobacco smoking and a BMI of 27.5kg/m
2
 or 
more were associated with more postoperative complications after 
open appendicectomy in patients with non-perforated appendicitis. 
(62)
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MATERIALS AND METHODS 
SOURCE OF DATA : 
       Patients admitted in surgical wards at Coimbatore Medical College 
Hospital for any major elective abdominal surgeries between   September 
2013 - August 2014  
 
SAMPLE SIZE : n = 100 patients.  
 
METHODS OF COLLECTION OF DATA : 
Inclusion Criteria 
• Patients admitted for any major elective abdominal surgery 
including malignancy under the department of surgery in 
Coimbatore Medical College Hospital.  
• Both males and females >12 yrs are included in the study. 
• Under Hernias- epigastric, incisional and Para umbilical hernias  
Exclusion Criteria 
• Children < 12 yrs 
• Patients who have Icterus, severe anemia < 7 gm/dl, diabetes 
mellitus, chronic renal disease, chronic liver disease and patients 
on steroids or chemotherapy - both malignant and non malignant 
cases. 
• Under hernias -Inguinal and femoral hernias.  
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Methods 
• Details of cases will be recorded including history, clinical 
examination, investigations done, surgical procedures and post 
operative complications. 
• Anthropometry – height and weight recorded.  
• Follow up till discharge from the hospital.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 The study was conducted 
underwent any major elective abdominal surgery in Coimbatore Medical 
College Hospital, Coimbatore from September 2013 to 
100 patient, 42 patients developed complications and 58 had an uneventful 
recovery. 
SEX DISTRIBUTION 
Among the 100 patients under study 42 were female and 58 were male.
Frequency Table 
  Frequency
Valid FEMALE 
MALE 
Total 
 
MALE, 58
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RESULTS 
 on 100 patients between 15 - 85
August 2014. Among 
SEX 
 Percent 
Valid 
Percent 
Cumulative
Percent
42 42.0 42.0 42.0 
58 58.0 58.0 100.0
100 100.0 100.0  
 
FEMALE, 42
Gender Distribution 
 years who 
 
 
 
 
AGE WISE DISTRIBUTION OF 
The following is the age wise distribution of the study subjects
 
 
 
 
 
Vaild 
< 20 years 
20 - 39 years 
40 - 59 years 
> 59 years 
Total 
The maximum number of study subjects were in the age group of 40
59 years accounting for 45 % and there was only one subject below 20 years 
(15 years) 
 
 
1
0
5
10
15
20
25
30
35
40
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50
< 20 years
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SUBJECTS
Frequency Percent 
Valid 
Percent 
Cumulative 
1 1.0 1.0 
25 25.0 25.0 
45 45.0 45.0 
29 29.0 29.0 
100 100.0 100.0 
 
 
25
45
29
20 - 39 years 40 - 59 years > 59 years
Distribution of Age
 
 
Percent 
1.0 
26.0 
71.0 
100.0 
 
 
-
DISTRIBUTION OF MALIGNANT AND NON 
MALIGNANT CASES
MALIGNANT & NON 
  
Valid Malignant
Non 
Malignant
Total 
 
In our study of 100 cases 40 were malignant and 60 were non malignant.
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Malignant
70 
 
 
MALIGNANT 
Frequency Percent 
Valid 
Percent 
Cumulative 
Percent
 40 40.0 40.0 40.0
 
60 60.0 60.0 100.0
100 100.0 100.0  
 
40
60
Non Malignant
Malignant & Non Malignant
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DISTRIBUTION OF MALIGNANCIES BETWEEN SEX 
 
  
MNM 
Total Malignant 
Non 
Malignant 
SEX FEMALE Count 14 28 42 
% within SEX 33.3% 66.7% 100.0% 
% within 
MNM 
35.0% 46.7% 42.0% 
MALE Count 26 32 58 
% within SEX 44.8% 55.2% 100.0% 
% within 
MNM 
65.0% 53.3% 58.0% 
 
 
Total 
Count 40 60 100 
% within SEX 40.0% 60.0% 100.0% 
% within 
MNM 
100.0% 100.0% 100.0% 
 
 
 
 
 
 
 
 
 
 
Female Male 
Malignant 33.3% 44.8% 
Non Malignant 66.7% 55.2% 
Most of the malignant subjects in our 
among the non malignant 60 subjects most of them were males ( 55.2 %).
 
 
 
 
33.3%
0.0%
10.0%
20.0%
30.0%
40.0%
50.0%
60.0%
70.0%
Female
Comparison of Malignancy with Gender
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study were females ( 66.7%) and  
44.8%
66.7%
Male
Malignant Non Malignant
 
 
55.2%
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DISTRIBUTION OF MALIGNANCIES AMONG VARIOUS 
AGE GROUPS 
  
MNM 
Total Malignant 
Non 
Malignant 
Agerange < 20 years Count 0 1 1 
% within 
AGERANGE 
0.0% 100.0% 100.0% 
% within 
MNM 
0.0% 1.7% 1.0% 
20 - 39 
years 
Count 5 20 25 
% within 
AGERANGE 
20.0% 80.0% 100.0% 
% within 
MNM 
12.5% 33.3% 25.0% 
40 - 59 
years 
Count 15 30 45 
% within 
AGERANGE 
33.3% 66.7% 100.0% 
% within 
MNM 
37.5% 50.0% 45.0% 
> 59 years Count 20 9 29 
% within 
AGERANGE 
69.0% 31.0% 100.0% 
% within 
MNM 
50.0% 15.0% 29.0% 
Total Count 40 60 100 
% within 
AGERANGE 
40.0% 60.0% 100.0% 
% within 
MNM 
100.0% 100.0% 100.0% 
 
 
 
 
 < 20 years
20 - 39 years
40 - 59 years
> 59 years
 
Most of the malignant cases in our study were greater than 59 years 
and most of the non malignant cases were distributed in the 40 
group. 
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POST SURGICAL COMPLICATIONS
 
  
Valid Absent 
Present 
Total 
Post operative complications were present in 42 percent of the study 
subjects. 
Present, 42
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Frequency Percent 
Valid 
Percent 
Cumulative
Percent
58 58.0 58.0 58.0
42 42.0 42.0 100.0
100 100.0 100.0  
 
 
 
Absent, 58
Complications
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The varied complications and their distribution is tabulated below 
 
COMPLICATIONS 
    Frequency Percentage 
Valid 
Percent 
Cumulative 
Percent 
Valid Burst abdomen 1 58.0 58.0 58.0 
Fistula 2 1.0 1.0 59.0 
LRTI + Pleural 
effusion 
6 2.0 2.0 61.0 
Mortality 1 6.0 6.0 67.0 
Seroma 5 1.0 1.0 68.0 
Wound 
infection 
27 5.0 5.0 73.0 
27.0 27.0 100.0 
Total 100 100.0 100.0  
 
 
 
0
5
10
15
20
25
30
Burst 
abdomen
Fistula LRTI+Pleural 
effusion
Mortality Seroma Wound 
infection
Frequency of Complications 
Frequency
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COMPARISON OF COMPLICATIONS WITH GENDER 
 
  
COMP 
Total No Yes 
SEX FEMALE Count 25 17 42 
% within 
SEX 
59.5% 40.5% 100.0% 
% within 
COMP 
43.1% 40.5% 42.0% 
MALE Count 33 25 58 
% within 
SEX 
56.9% 43.1% 100.0% 
% within 
COMP 
56.9% 59.5% 58.0% 
Total Count 58 42 100 
% within 
SEX 
58.0% 42.0% 100.0% 
% within 
COMP 
100.0% 100.0% 100.0% 
 
 
Female Male 
Absent 59.5% 56.9% 
Present 40.5% 43.1% 
Among the female study subjects 59.5 % developed 
among the male subjects 56.9% had morbid postoperative hospital stay with 
complications.  
59.5%
0.0%
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40.0%
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Comparison of Complications with Gender
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COMPARISON OF COMPLICATIONS WITH AGE RANGE 
  
COMP 
Total 
No Yes 
AGERANGE < 20 
years 
Count 0 1 1 
% within 
AGERANGE 
0.0% 100.0% 100.0% 
% within 
COMP 
0.0% 2.4% 1.0% 
20 - 
39 
years 
Count 13 12 25 
% within 
AGERANGE 
52.0% 48.0% 100.0% 
% within 
COMP 
22.4% 28.6% 25.0% 
40 - 
59 
years 
Count 32 13 45 
% within 
AGERANGE 
71.1% 28.9% 100.0% 
% within 
COMP 
55.2% 31.0% 45.0% 
> 59 
years 
Count 13 16 29 
% within 
AGERANGE 
44.8% 55.2% 100.0% 
% within 
COMP 
22.4% 38.1% 29.0% 
Total Count 58 42 100 
% within 
AGERANGE 
58.0% 42.0% 100.0% 
% within 
COMP 
100.0% 100.0% 100.0% 
  
 
 
The frequency of complications increased as age advances with the 
maximum brunt of complications in subjects aged greater than 59years. The 
study subjects aged 40 
within their age group. In the subjects between 20 
and without complications were equal.
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- 59 years had lesser percentage of complications 
- 39 years , subjects with 
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Absent Present 
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- 39 years 13 12 
- 59 years 32 13 
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DISTRIBUTION OF SERUM ALBUMIN LEVEL
SERUM AMBUMN 
LEVEL 
 
Valid 2.0 - 2.5 
2.6 - 3.0 
3.1 - 3.5 
3.6 - 4.0 
4.1 - 4.5 
Total 
 
 
Most of the study subjects had albumin levels below desired values 
(less than 3.5 g/dl- 83 %) 
albumin values between 3 and 3.5
1
0 5
2.0 - 2.5
2.6 - 3.0
3.1 - 3.5
3.6 - 4.0
4.1 - 4.5
Distribution of Serum Albumin level
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Frequency Percent 
Valid 
Percent 
Cumulative
Percent
11 11.0 11.0 
30 30.0 30.0 
42 42.0 42.0 
16 16.0 16.0 
1 1.0 1.0 
100 100.0 100.0   
    
 
within the maximum subjects having serum 
 g/dl ( 42%). 
11
30
16
10 15 20 25 30 35 40
Series1
 
 
 
11.0 
41.0 
83.0 
99.0 
100.0 
 
    
42
45
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COMPARISON OF BETWEEN MALIGNANCY WITH 
SERUM ALBUMIN LEVEL 
  
MNM 
Total Malignant 
Non 
Malignant 
Serumlevel 2.0 - 
2.5 
Count 10 1 11 
% within 
SERUMLEVEL 
90.9% 9.1% 100.0% 
% within MNM 25.0% 1.7% 11.0% 
2.6 - 
3.0 
Count 15 15 30 
% within 
SERUMLEVEL 
50.0% 50.0% 100.0% 
% within MNM 37.5% 25.0% 30.0% 
3.1 - 
3.5 
Count 13 29 42 
% within 
SERUMLEVEL 
31.0% 69.0% 100.0% 
% within MNM 32.5% 48.3% 42.0% 
3.6 - 
4.0 
Count 2 14 16 
% within 
SERUMLEVEL 
12.5% 87.5% 100.0% 
% within MNM 5.0% 23.3% 16.0% 
4.1 - 
4.5 
Count 0 1 1 
% within 
SERUMLEVEL 
0.0% 100.0% 100.0% 
% within MNM 0.0% 1.7% 1.0% 
Total Count 40 60 100 
% within 
SERUMLEVEL 
40.0% 60.0% 100.0% 
% within MNM 100.0% 100.0% 100.0% 
2.0 - 2.5 
2.6 - 3.0 
3.1 - 3.5 
3.6 - 4.0 
4.1 - 4.5 
Most of the malignant cases had albumin levels less than 3 with the 
number of subjects maximum 
significant (p value < 0.0001)
albumin levels greater than 3 with the maximum
range which was again statistically significant ( p value less tha
0
5
10
15
20
25
30
2.0 - 2.5
Comparison between Malignancy with Serum 
83 
Malignant Non Malignant 
10 1 
15 15 
13 29 
2 14 
0 1 
 
 
in the 2.6 - 3 range which was statistically 
 Most of the non malignant cases had their 
 number in the 3.1 to 3.5 
n 0.001)
2.6 - 3.0 3.1 - 3.5 3.6 - 4.0 4.1 - 4.5
Albumin level
Malignant Non Malignant
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COMPARISON SERUM ALBUMIN LEVEL WITH 
COMPLICATIONS 
The study subjects who were underwent any major abdominal surgery 
and developed post operative complications mostly had their albumin levels 
less than 3 which was statistically  highly significant ( p value <0.0001)  
  
COMP 
Total No Yes 
SERUMLEVEL 2.0 
- 
2.5 
Count 2 9 11 
% within 
SERUMLEVEL 
18.2% 81.8% 100.0% 
% within COMP 3.4% 21.4% 11.0% 
2.6 
- 
3.0 
Count 7 23 30 
% within 
SERUMLEVEL 
23.3% 76.7% 100.0% 
% within COMP 12.1% 54.8% 30.0% 
3.1 
- 
3.5 
Count 32 10 42 
% within 
SERUMLEVEL 
76.2% 23.8% 100.0% 
% within COMP 55.2% 23.8% 42.0% 
3.6 
- 
4.0 
Count 16 0 16 
% within 
SERUMLEVEL 
100.0% 0.0% 100.0% 
% within COMP 27.6% 0.0% 16.0% 
4.1 
- 
4.5 
Count 1 0 1 
% within 
SERUMLEVEL 
100.0% 0.0% 100.0% 
% within COMP 1.7% 0.0% 1.0% 
Total Count 58 42 100 
% within 
SERUMLEVEL 
58.0% 42.0% 100.0% 
% within COMP 100.0% 100.0% 100.0% 
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2.6 - 3.0 
3.1 - 3.5 
3.6 - 4.0 
4.1 - 4.5 
2.0 - 2.5 
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3.1 - 3.5 
3.6 - 4.0 
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- 3.0 3.1 - 3.5 3.6 - 4.0 4.1 
Absent Present
Absent Present 
2 9 
7 23 
32 10 
16 0 
1 0 
Percentage 
81.8% 
76.7% 
23.8% 
0.0% 
0.0% 
 
- 4.5
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Subjects with albumin levels greater than 3.5 did not suffer any major 
post operative complication during hospital stay. 
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40 10
< 18.5 (Under nutrition )
18.5 - 24.9 ( Normal )
25.0 - 30.0 (Over weight )
Distribution of BMI
DISTRIBUTION OF BMI 
BMI LEVEL Frequency
Valid < 18.5 
(Under 
nutrition ) 
18.5 - 24.9  
( Normal ) 
25.0 - 30.0 
(Over 
weight ) 
Total 
Most of the patients were distributed
between 18.5 kg/m
2
 and 24.9
study were underweight by BMI in our study.
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26
70
20 30 40 50 60 70
 
BMI  LEVEL 
 Percent 
Valid 
Percent 
Cumulative 
Percent
26 26.0 26.0 26.0
70 70.0 70.0 96.0
4 4.0 4.0 100.0
100 100.0 100.0   
 
 in the normal BMI range 
 kg/m
2
. One quarter of the population under 
 
80
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COMPARISON OF MALIGNANCY WITH BMI 
RANGE  
  
MNM 
Total Malignant 
Non 
Malignant 
BMILEVEL < 18.5 
(Under 
nutrition ) 
Count 14 12 26 
% within 
BMILEVEL 
53.8% 46.2% 100.0% 
% within 
MNM 
35.0% 20.0% 26.0% 
18.5 - 24.9 
( Normal ) 
Count 26 44 70 
% within 
BMILEVEL 
37.1% 62.9% 100.0% 
% within 
MNM 
65.0% 73.3% 70.0% 
25.0 - 30.0 
(Over 
weight ) 
Count 0 4 4 
% within 
BMILEVEL 
0.0% 100.0% 100.0% 
% within 
MNM 
0.0% 6.7% 4.0% 
Total Count 40 60 100 
% within 
BMILEVEL 
40.0% 60.0% 100.0% 
% within 
MNM 
100.0% 100.0% 100.0% 
 
 
05
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15
20
25
30
35
40
45
< 18.5 
Comparison of Malignancy with BMI range
 
 
 
 
 
 
 
 
There was no significant difference statistically with regards to the 
distribution of BMI between the malignant and non malignant study groups.
 
 
< 18.5  
18.5 - 24.9 
25.0 - 30.0 
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18.5 - 24.9 25.0 - 30.0
Malignant Non Malignant
 
Malignant Non Malignant 
14 12 
26 44 
0 4 
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COMPARISON OF COMPLICATIONS WITH BMI RANGE 
 
  
COMP 
Total No Yes 
BMI 
LEVEL 
< 18.5 
(Under 
nutrition ) 
Count 4 22 26 
% within  
BMI LEVEL 
15.4% 84.6% 100.0% 
% within COMP 6.9% 52.4% 26.0% 
18.5 - 24.9 
 ( Normal ) 
Count 50 20 70 
% within  
BMI LEVEL 
71.4% 28.6% 100.0% 
% within COMP 86.2% 47.6% 70.0% 
25.0 - 30.0 
(Over 
weight ) 
Count 4 0 4 
% within  
BMI LEVEL 
100.0% 0.0% 100.0% 
% within COMP 6.9% 0.0% 4.0% 
Total Count 58 42 100 
% within  
BMI LEVEL 
58.0% 42.0% 100.0% 
% within COMP 100.0% 100.0% 100.0% 
 
 
 
 
< 18.5 (Under 
nutrition )
18.5 - 24.9 ( 
Normal )
25.0 - 30.0 
(Over weight )
0
5
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Absent Present 
 
4 22 
 
50 20 
 
4 0 
 
 
 
 
18.5 - 24.9 ( Normal ) 25.0 - 30.0 (Over weight )
Absent Present
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There was a statistically significant increase in the number of 
complications as BMI decreases with the maximum percentage of 
complications in the underweight BMI group.  
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Persence of Complications with BMI
Percentage
Percentage 
< 18.5 (Under nutrition ) 84.6% 
18.5 - 24.9 ( Normal ) 28.6% 
25.0 - 30.0 (Over weight ) 0.0% 
MEAN SERUM ALBUMIN AND BMI WITH REGARDS TO 
INCIDENCE OF COMPLICATIONS
On an average patients with albumin levels averaging around 2.8 
preoperatively were subjected to
observation. 
And further patients with 3.3
complications postoperatively
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  post operative complications
 g/dl and higher had lesser incidence of 
. 
3.362
2.821
Present
level
Serum level
 
g/dl 
 in our 
  
 
 
BMI around 19.2
postoperative complications and BMI 
associated with lesser complication rates.
 
 
 
22.410
18.000
18.500
19.000
19.500
20.000
20.500
21.000
21.500
22.000
22.500
23.000
Absent
Comparison of Complications with BMI
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kg/m
2
 as the mean was associated with higher 
of 22.4 kg/m
2
 and higher was 
 
 
19.710
Present
BMI
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COMPLICATIONS IN NON MALIGNANT CASES 
 
 
  
COMPLICATIONS 
Total Absent Present 
DIAGNOSIS CBD 
Calculus & 
Cholelithiasis 
Count 8 3 11 
% within 
DIAGNOSIS 
72.7% 27.3% 100.0% 
Incisional 
Hernia 
Count 8 5 13 
% within 
DIAGNOSIS 
61.5% 38.5% 100.0% 
Umbilical & 
Paraumbilical 
Hernia 
Count 9 4 13 
% within 
DIAGNOSIS 
69.2% 30.8% 100.0% 
Pseudocyst 
of pancreas 
Count 6 6 12 
% within 
DIAGNOSIS 
50.0% 50.0% 100.0% 
Others Count 10 1 11 
% within 
DIAGNOSIS 
90.9% 9.1% 100.0% 
Total Count 41 19 60 
% within 
DIAGNOSIS 
68.3% 31.7% 100.0% 
 
  
With special regards to non malignant 
operative complications was maximum with a preoperative diagnosis of 
pseudocyst of pancreas with patients in the group having serum albumin 
3.2g/dl on an average and 21
cystogastrostomy followed by open incisional hernia repair
hernioplasty. 
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cases, the incidence of post 
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DISCUSSION 
 
 Organic defence decrease and malnutrition were recognised as 
potential factors for higher morbidity and mortality rates in the post 
operative period. Malnourished patients are at a higher risk of postoperative 
complications and death, if compared to well nourished patients subjected to 
similar surgeries. 
 Nutritional assesment is therefore essential in order to identify patients 
who are at an increased risk of developing post operative complications. 
Though numerous studies have evaluated different nutritional indices , serum 
albumin and body mass index as markers of assesing post operative 
morbidity and mortality have been taken up in certain studies. 
 Serum albumin levels less than 3g/dl was associated with increased 
post operative morbidity according to the study by Mullen et al, Golub et al , 
Leite et al. 
 Our study also attributes itself to similar results with patients having 
albumin levels lesser than 3 g/dl suffering from significantly higher 
complications in the form of seroma , wound gaping, lower respiratory tract 
infections, mortality , fistula when compared with patients having higher 
albumin levels. Most of the patients in our study had albumin levels ranging 
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 Gibbs et al observed in his study that a fall in serum albumin levels 
from 4.6 g/dl to 2.1 g/dl was associated with exponential increase in 
mortality rates from less than 1% to 29% in morbidity rates from 10% to 
65%. Albumin thus was evaluated as the strongest predictor of mortality and 
morbidity for surgery as a whole. It was a better predictor of some types of 
morbidity, particularly sepsis and major infections , than other types and was 
a very useful prognostic marker according to the study. 
 The post operative complications were more in female than males in 
the above studies. Our study also had a slight preponderence to females with 
respect to complications during post operative hospital stay. 
 Complications also had an exponential increase as age advances as is 
also evident in our study with complications more with age groups greater 
than 59 years . 
Varut Lohsiriwat et al in their study demonstrated that pre operative 
hypoalbunemia is a major risk factor for post operative complications 
following rectal cancer surgeries. This suggests pre operative 
hypoalbuminemia is an independent risk factor for post operative 
complications following rectal cancer surgeries as well as post operative 
bowel function and hospital stay. Our study also shows that lower serum 
albumin levels and increased incidence of complications among the malignat 
population as compared to the non malignant patients. 
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 Engelman et al observed that albumin levels less than 2.5 g/dl and 
BMI less than 20 kg/m2  was associated with increased post operative 
complications.  
 In our study the post operative complications increased as the albumin 
levels decreased from 3 g/ dl to lesser levels and also as regards BMI, the 
complications were more with patients with underweight measuring less than 
18.5 kg/m
2
. 
Similar results were also put forward by a prospective cohort study done by 
Mullen et al on impact of Body Mass Index on perioperative outcomes in 
patients undergoing major intra abdominal surgeries where they concluded 
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that patients who were underweight had a fivefold increase in post operative 
mortality , perhaps as a consequence of their underlying nutritional status. 
 In a study by Michael et al on malnutrition , outcome and nutritional 
support suggest pre operative nutritional risk indications like BMI < 18.5 
kg/m
2
 and serum albumin < 2.1 g/dl have an impact on surgical outcome. 
Such patients are evidently malnourished and consequently have longer 
hospital stays and experience a 40 -60% greater frequency of complications 
in response to medical / surgical treatment. 
 In addition our study also evaluated the differences in complications 
among the non malignant cases and revealed that post operative 
complications were at a higher incidence among patients with a preoperative 
diagnosis of pseudocyst of pancreas undergoing cystogastrostomy followed 
by incisional hernia undergoing hernioplasty.  
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CONCLUSION 
 
 Serum albumin is thus validated as a single important marker 
indicative of post operative complications , depicting the individual's 
nutritional status and highly indicative of post operative morbidity and 
mortality. 
In our study of 100 patients, the complication rate was more when serum 
albumin level was less than 3 g/dl which was statistically significant. The 
rate of complications decreased as serum albumin level increased from  3.1 
g/dl and above. Patients with serum albumin level greater than 3.5 g/dl had 
lesser complications which was statistically significant irrespective of 
malignant or non malignant disease pathology. 
 Thus serum albumin is a better predictor of surgical outcomes than 
many other preoperative patient characteristics. It is comparabily a low cost 
test that is widely performed and with its esteemed value should be used 
more frequently as a prognostic tool to detect malnutrition and risk of 
adverse surgical outcomes. 
BMI in underweight category is also associated with statistically 
significant post operative complications. 
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There was no statistically significant sex preponderence with regards 
to complication rates. 
The disease process also plays a role in post operative complication 
rates as evidenced in our study as the complication rates were higher in the 
malignant population which was statistically significant and among the non 
malignant group, complications were more with patients having pseudocyst 
of pancreas undergoing cystogastrostomy. 
Thus serum albumin and BMI can be used as an easy, cost effective 
and highly reliable tools in predicting post operative complications and thus 
effective preoperative nutritional supplementation can be given to reduce 
morbidity and mortality in the long run.  
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PROFORMA 
 
NAME:        D.O.A:  
AGE:        D.O.D:  
SEX:             IP/OP NO:  
EDUCATION:  
OCCUPATION:  
ADDRESS:  
CHIEF COMPLAINTS:  
 
HOPI:  
 
 
PAST HISTORY:  
 
 
FAMILY HISTORY:  
 
PERSONAL HISTORY:  
 
 
 
110 
 
GENERAL PHYSICAL EXAMINATION: 
HEIGHT_______cms  
WEIGHT________kgs  
BMI: <18.5  
          18.5-24.9  
          25-29.9  
            >30  
PULSE__________/min  
BP_____/______mm/hg  
PALLOR:  
ICTERUS:  
PEDAL EDEMA:  
LYMPHADENOPATHY:  
SYSTEMIC EXAMINATION:  
RS:  
CVS:  
PA:  
LOCAL EXAMINATION:  
 
DIAGNOSIS:  
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INVESTIGATIONS:  
BLOOD ROUTINE:  
URINE ROUTINE:  
SERUM ALBUMIN: 
 <3.5g/dl  
>3.5g/dl  
MANAGEMENT:  
 
SURGERY PERFORMED:  
 
POSTOPERATIVE PROGRESS:  
 
WOUND INFECTION :  
DISCHARGE : 
LEAK : 
DEHISCENCE : 
 
OTHERS:  
 
MORTALITY: 
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S. No
NAME
AGE/SEX IP.NO DIAGNOSIS TREATMENT
MALIGNANT/NON-
MALIGNANT
SERUM 
ALBUMI
N
BMI
COMPLIC
ATIONS-
YES/NO
COMPLICATIONS
1
Aashiya Begum
44/F 36783 Retroperitoneal GIST
Wide local excision with splenectomy with distal 
pancreatectomy with partial gastrectomy
MALIGNANT 2.7 18.1 yes wound infection
2
Achikam
60/F 28872 Carcinoma  Stomach Billroth II Gasterectomy with Jejunojejenostomy MALIGNANT 2.9 19.8 yes wound infection
3 Ali Rehmath 53/F 7705 Incisional Hernia Open Hernioplasty NON-MALIGNANT 3.4 22.8 yes seroma
4 Ammaiyappan 64/M 21731 Carcinoma  Stomach Billroth II Gasterectomy with Jejunojejenostomy MALIGNANT 3.3 19.5 yes wound infection
5 Appavu 72/M 45254 Carcinoma  Stomach Billroth II Gasterectomy with Jejunojejenostomy MALIGNANT 2.4 17.9 yes LRTI+pleural effusion
6 Arun Prakash 35/M 75913 Pseudocyst of pancreas Cystogastrostomy NON-MALIGNANT 3.8 26.1 no
7 Ashwin 15/M 10176 Ventral Hernia Open Hernioplasty NON-MALIGNANT 2.9 18.3 yes wound infection
8 Balan 30/M 16825 Retroperitoneal Mass Excision MALIGNANT 3.2 20.5 no
9 Balasubramani 52/M 62626 Pseudocyst of pancreas Cystgastrojejunostomy NON-MALIGNANT 3.1 23.8 yes wound infection
10 Barkhath Ali Khan 30/M 29750 Umbilical hernia Open Hernioplasty NON-MALIGNANT 3.9 23.5 no
11
Chandrashekar
60/M 28874 Periampullary Carcinoma Whipple's Procedure MALIGNANT 2.4 18 yes fistula
12 Chelladurai 76/M 75709 Carcinoma  Stomach Billroth II Gasterectomy with Jejunojejenostomy MALIGNANT 2.9 17.7 yes LRTI+pleural effusion
13 Chinnal 65/F 10682 Carcinoma stomach Billroth II Gasterectomy with Jejunojejenostomy MALIGNANT 2.9 20.8 yes wound infection
14 Deepa 31/F 4686 Incisional Hernia Open hernioplasty NON-MALIGNANT 3.1 24 yes seroma
15 Deivanai 52/F 14352 Splenic Flexure Growth Left Hemicolectomy MALIGNANT 3.2 20.2 no
16 Devaraj 40/M 71623 Cholelithiasis Open Cholecystectomy NON-MALIGNANT 4 23.7 no
17 Dhandapani 46/M 4642 Carcinoma  Stomach Billroth II Gasterectomy with Jejunojejenostomy MALIGNANT 2.3 18.4 no
18 Durgadevi 20/F 50879 Pseudocyst of pancreas Cystogastrostomy NON-MALIGNANT 3.3 17.7 yes wound infection
19 Ganesan 60/M 50392 Carcinoma Esophagus Transhiatal esophagectomy MALIGNANT 2.8 20.5 yes wound infection
20 Gopal 67/M 53321 Carcinoma  Stomach Billroth II Gasterectomy with Jejunojejenostomy MALIGNANT 2.9 22.1 no
21 Govindasamy 56/M 74152 Umbilical hernia Open Hernioplasty NON-MALIGNANT 3.3 23.4 no
22 Ishwari 45/F 19704 Carcinoma  Stomach Billroth II Gasterectomy with Jejunojejenostomy MALIGNANT 3.8 20.3 no
23 Janaki 44/F 4220 Subacute appendicitis Open appendicectomy (others) NON-MALIGNANT 4.4 23.2 no
24
Jebamalraj
56/M 71453
Subacute intestinal 
obstruction with stricture 
ileum
Resection with ileotransverse anastomosis (others) NON-MALIGNANT 3.2 23.8 no
25 Jemini 57/M 31193 Periampullary Carcinoma Whipple's Procedure MALIGNANT 2.8 18.8 yes mortality
MASTER CHART 
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26 Jennith Nisha 43/F 3064 Subacute cholecystitis Open cholecystectomy (others) NON-MALIGNANT 3.5 24.8 no
27 Jeyaraj 32/M 16854 Carcinoma Rectum APR with End Colostomy MALIGNANT 2.8 20.2 yes wound infection
28
Jothimani
43/F 21773
Adenocarcinoma 
Gallbladder
Open Cholecystectomy MALIGNANT 2.3 17.8 yes wound infection
29 Kaliveeran 77/M 48847 Carcinoma  Stomach Billroth II Gasterectomy with Jejunojejenostomy MALIGNANT 2.5 18.3 yes wound infection
30 Kaliyammal 48/F 46611 Cholelithiasis Open Cholecystectomy NON-MALIGNANT 2.9 17.9 yes wound infection
31 Kalleshwari 30/F 59548 Umbilical hernia Open Hernioplasty NON-MALIGNANT 3.7 25.8 no
32 Kannamal 47/F 26230 Choledocholithiasis Cholecystectomy with CBD exploration NON-MALIGNANT 3.1 24.1 no
33 Kannan 66/M 163446 Splenic Flexure Growth Left Hemicolectomy MALIGNANT 2.9 18.3 yes wound infection
34 Kannan 36/M 76509 TAO left lower limb Lumbar sympathectomy (others) NON-MALIGNANT 3.9 23.4 no
35 Karuppasamy 75/M 78968 Rectosigmoid growth APR with End Colostomy MALIGNANT 2.9 21.5 yes burst abdomen
36 Karuppasamy 31/M 76800 Cholelithiasis Open Cholecystectomy NON-MALIGNANT 2.8 17.8 yes wound infection
37 Kavitha 34/M 62539 Incisional Hernia Open Hernioplasty NON-MALIGNANT 2.9 18.4 yes wound infection
38 Krishnan 67/M 3842 CA ANAL CANAL APR with End Colostomy MALIGNANT 3.2 18.7 no
39 Krishnan 75/M 26221 Carcinoma  Stomach Billroth II Gasterectomy with Jejunojejenostomy MALIGNANT 2 18.4 yes LRTI+pleural effusion
40 Kumar 34/M 11614 Rectosigmoid growth APR with End Colostomy MALIGNANT 3.2 20.4 no
41 Lakshmi 40/F 42213 Calculous cholecystitis Open Cholecystectomy NON-MALIGNANT 3.5 22.8 yes wound infection
42 Lakshmi 35/F 3365 Incisional Hernia Open Hernioplasty NON-MALIGNANT 2.7 18 yes wound infection
43 Lakshmi 63/F 36297 Paraumbilical Hernia Open Hernioplasty NON-MALIGNANT 3.5 24 no
44
Lathadevi
45/F 13739
Carcinoma stomach with 
liver secondaries
Palliative Anterior Gastrojejunostomy MALIGNANT 3 20.3 no
45 Madan 34/M 19165 Pseudocyst of pancreas Cystogastrostomy NON-MALIGNANT 3.5 24 no
46 Madari 30/F 30868 Umbilical hernia Open Hernioplasty NON-MALIGNANT 2.9 23.2 yes seroma
47 Maheswari 38/F 53372 Incisional Hernia Open Hernioplasty NON-MALIGNANT 4 25.2 no
48 Mani 61/M 32274 Incisional Hernia Hernioplasty NON-MALIGNANT 2.9 18.4 no
49 Manikandan 48/M 43530 Pseudocyst of pancreas Cystogastrostomy NON-MALIGNANT 3.4 22.1 yes LRTI+pleural effusion
50 Manjula 45/F 29703 Carcinoma Rectum Low Anterior Resection with colostomy MALIGNANT 3.2 21.2 no
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51 Mariappann 36/M 61516 Pseudocyst of pancreas Cystgastrojejunostomy NON-MALIGNANT 2.7 22.8 yes LRTI+pleural effusion
52
Mariyayee
37/F 69022
Carcinoma Head of 
pancreas
Palliative Triple bypass MALIGNANT 2.3 18 yes wound infection
53 Michel 46/M 50989 Incisional Hernia Open Hernioplasty NON-MALIGNANT 3.7 22.7 no
54 Murali 25/M 29770 Pseudocyst of pancreas Cystogastrostomy NON-MALIGNANT 2.8 19.1 yes fistula
55 Murugan 48/M 70946 Periampullary Carcinoma Whipple's Procedure MALIGNANT 3.4 21.1 no
56 Murugan 40/M 7765 Choledocholithiasis CBD exploration NON-MALIGNANT 3.7 23.2 no
57 Murugan 47/M 68410 Pseudocyst of pancreas Cystogastrostomy NON-MALIGNANT 2.7 18.1 no
58 Murugesan 50/M 42325 Carcinoma  Stomach Billroth II Gasterectomy with Jejunojejenostomy MALIGNANT 2.9 21 yes wound infection
59
Myilsamy
75/M 79423
Gastrointestinal Stromal 
Tumour
Excision MALIGNANT 2.9 20 no
60 Nagarathinam 52/F 17013 Umbilical hernia Open Hernioplasty NON-MALIGNANT 3.5 23.5 no
61
Nataraj
63/M 30679
Tuberculous Abdomen 
with ileal stricture
Resection with ileoclic anastomosis (others) NON-MALIGNANT 2.4 18.2 no
62 Omana 49/F 13079 Incisional Hernia Open Hernioplasty NON-MALIGNANT 4 22.4 no
63
Palanisamy
60/M 31182
Synchronous 
Adenocarcinoma Rectum 
and Descending colon
Hartman s procedure with end colostomy MALIGNANT 2.8 18.3 yes wound infection
64 Palanisamy 37/M 58375 Carcinoma Sigmoid Colon AR with end colostomy MALIGNANT 3.2 21 yes wound infection
65 Pappathy 47/F 33124 Carcinoma Rectum APR with End Colostomy MALIGNANT 3.2 22.5 no
66 Pongiammal 63/F 43043 Carcinoma  Stomach Billroth II Gasterectomy with Jejunojejenostomy MALIGNANT 3.4 21.1 no
67 Ponnammal 60/F 4530 CBD calculus Cholecystectomy with CBD exploration NON-MALIGNANT 3.3 23 no
68 Ponnuram 68/M 8467 Carcinoma  Stomach Billroth II Gasterectomy with Jejunojejenostomy MALIGNANT 3.3 21.8 no
69 Poongodi 85/F 3074 Subacute appendicitis Open appendicectomy  (others) NON-MALIGNANT 3.8 24.5 no
70 Poovathal 45/F 30892 Umbilical hernia Open Hernioplasty NON-MALIGNANT 2.6 18.1 yes seroma
71 Rajalakshmi 45/F 3066 Incisional Hernia Open hernioplasty NON-MALIGNANT 3.8 24.9 no
72 Rajamani 62/F 38291 Incisional Hernia  Open Hernioplasty NON-MALIGNANT 2.8 17.9 yes wound infection
73 Rajammal 80/F 36241 Cholelithiasis Open Cholecystectomy NON-MALIGNANT 3.1 23 no
74 Rajan 50/M 30952 Carcinoma  Anal Canal End Colostomy MALIGNANT 3.3 20.1 no
75 Rajathangam 53/F 38691 Paraumbilical Hernia Open Hernioplasty NON-MALIGNANT 3.1 22.7 no
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76 Rajeswari 32/F 47786 Calculous cholecystitis Cholecystectomy with CBD exploration NON-MALIGNANT 3.3 24.2 no
77 Rajeswari 30/F 18445 Incisional Hernia Open Hernioplasty NON-MALIGNANT 3.2 22.8 no
78 Ramai 75/F 45798 Carcinoma  Rectum APR with End Colostomy MALIGNANT 2.4 18.1 yes LRTI+pleural effusion
79 Ramajayam 61/M 40483 Umbilical hernia Open Hernioplasty NON-MALIGNANT 2.7 23.2 no
80 Ramalakshmi 47/F 42596 Incisional Hernia Open Hernioplasty NON-MALIGNANT 3.4 22.8 no
81 Raman 39/F 3330 Subacute appendicitis Open appendicectomy (others) NON-MALIGNANT 3.4 23.7 no
82 Ramasamy 57/M 51370 Chronic calcific Puestow s procedure (others) NON-MALIGNANT 3.1 21.8 no
83 Ramaswamy 58/M 10825 Pseudocyst of pancreas Cystogastrostomy NON-MALIGNANT 3.4 23.8 no
84 Ranganath 55/M 41817 Incisional Hernia Open Hernioplasty NON-MALIGNANT 3.6 26.3 no
85 Rangasamy 49/M 40145 Umbilical hernia Open Hernioplasty NON-MALIGNANT 3.4 22.5 no
86 Ravi 43/M 56263 Pseudocyst of pancreas Cystogastrostomy NON-MALIGNANT 3.7 21.2 no
87 Sangeetha 23/F 32245 Cholelithiasis Open Cholecystectomy NON-MALIGNANT 3.4 22.8 no
88 Sapan Misthai 40/M 59587 Subacute appendicitis Open appendicectomy (others) NON-MALIGNANT 3.8 24.2 no
89 Sebaraj 56/M 28559 Pseudocyst of pancreas Cystogastrostomy NON-MALIGNANT 3.4 22.2 yes wound infection
90 ShalathMani 55/M 1337 Hydatid cyst liver Excision with marsupilisation (others) NON-MALIGNANT 3.2 23.4 no
91 Shanmugam 69/M 31394 Acute cholecystitis Open Cholecystectomy NON-MALIGNANT 3.3 23.2 no
92
Shivalingam
57/M 29614
Carcinoma  Rectosigmoid 
junction 
Anterior Resection MALIGNANT 2.1 18.2 yes wound infection
93 Suburaj 56/M 28559 Chronic calcific Puestow s procedure (others) NON-MALIGNANT 2.7 17.8 yes seroma
94 Sundarambal 67/F 5669 Carcinoma  Stomach Billroth II Gasterectomy with Jejunojejenostomy MALIGNANT 2.8 21.4 yes wound infection
95 Sunderraj 56/M 30742 Carcinoma  Stomach Billroth II Gasterectomy with Jejunojejenostomy MALIGNANT 3.4 20.1 no
96 Thambidurai 56/M 5629 Pseudocyst of pancreas Cystogastrostomy NON-MALIGNANT 3.1 22.7 no
97 Vetrivel 38/M 28943 Paraumbilical Hernia Open Hernioplasty NON-MALIGNANT 2.7 20.7 no
98 Vijaya 30/F 73471 Paraumbilical Hernia Open Hernioplasty NON-MALIGNANT 3.3 23.8 yes wound infection
99
Vijayakumar
63/M 56288
Carcinoma Descending 
Colon
Left Hemicolectomy MALIGNANT 2.3 17.7 yes wound infection
100 Vimalabhai 55/F 1759 Carcinoma Sigmoid Colon AR with end colostomy MALIGNANT 3.6 22.1 no
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ABBREVIATIONS 
 
BMI - Body Mass Index 
SSI - Surgical Site Infection 
MHMC - Mid Humeral Muscle Circumference 
TSF - Triceps Skin Fold thickness. 
DEXA - Dual Energy Xray Absorptiometry 
TLC - Total Lymphocyte Count 
PNI - Prognostic Nutritional Index 
CI - Catabolic Index 
DM  - Diabetes Mellitus 
BEE - Basal Energy Expenditure 
BMR - Basal Metabolic Rate 
RQ - Respiratory Quotient 
ECM - Extracellular Matrix 
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CONSENT FORM 
It has been explained to me in my mother tongue and I completely 
understand my condition and I have been explained in detail regarding this 
study - “Pre operative serum albumin and body mass index as predictors 
of postoperative morbidity and mortality in elective major surgeries”.    
I hereby give my consent to participate in the above mentioned study. 
 
 
Date: 
Place: 
 
 
  
      Signature/ thumb print of the patient 
      with name: 
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xg;g[jy;  gotk;; [ ; ;; [ ; ;; [ ; ; 
bgah; : 
ghypdk; :        taJ : 
Kfthp : 
 
 muR nfhit kUj;Jtf; fy;Y}hpapy; bghJ mWit  rpfpr]ir 
Jiwapy; gl;l gapYk; khztd; mth;fs; nkw;bfhs;Sk;  "mWit 
rpfpr;irf;F Kd; msf;fg;gLk; rPuk; my;g[kpd; kw;Wk; cly; epiw  ; ; ; ; ; ; ; ; [ ; ; ; ;; ; ; ; ; ; ; ; [ ; ; ; ;; ; ; ; ; ; ; ; [ ; ; ; ;
FwpaPl;blz; (; ;; ;; ; BMI)/ mWit rpfpr;irf;Fg; gpd;dh; Vw;gLk; neha[W ; ; ; ; ; ; ; [; ; ; ; ; ; ; [; ; ; ; ; ; ; [
kw;Wk; ,wg;g[ tpfpjj;ij mstpl cjt[kh; ; ; [ ; [; ; ; [ ; [; ; ; [ ; [ " Fwpj;j Ma;tpy; 
bra;Kiw kw;Wk; midj;J tptu';fisa[k; nfl;Lf; bfhz;L vdJ 
re;njf';fis bjspt[g;gLj;jpf; bfhz;nld; vd;gij bjhptpj;Jf; 
bfhs;fpnwd;. 
 ehd; ,e;j Ma;tpy; KG rk;kjj;JlDk;/ Ra rpe;jida[lDk; 
fye;J bfhs;s rk;kjpf;fpnwd;. 
 ,e;j Ma;tpy; vd;Dila midj;J tpgu';fs; 
ghJfhf;fg;gLtJld; ,jd; Kot[fs; Ma;tpjHpy; btspaplg;gLtjpy; 
Ml;nrgid ,y;iy vd;gij bjhptpj;Jf; bfhs;fpnwd;. ve;j 
neuj;jpYk; ,e;j Ma;tpypUe;J ehd; tpyfpf; bfhs;s vdf;F chpik 
cz;L vd;gija[k; mwpntd;. 
 
,lk;  :       ifbahg;gk; / nuif 
ehs; : 
 
 
